Description:
Acebrophylline Sustained Release Tablet is a bronchodilator and mucolytic agent used in the management of respiratory conditions such as asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). It works by relaxing the bronchial muscles and thinning the mucus in the airways, thereby making it easier to breathe and enhancing lung function. The sustained release formulation ensures a prolonged therapeutic effect with convenient once or twice-daily dosing.
Therapeutic Uses:
Treatment of bronchial asthma
Management of chronic obstructive pulmonary disease (COPD)
Relief from symptoms such as wheezing, breathlessness, and chest tightness associated with obstructive airway disorders
Mechanism of Action:
Acebrophylline combines the anti-inflammatory and mucolytic properties of ambroxol with the bronchodilatory effect of theophylline derivatives. It reduces airway inflammation, improves mucus clearance, and helps maintain open airways for better airflow.
Dosage Form:
Sustained Release Tablet
Prescription Status:
Prescription-only medication
Note:
Acebrophylline should be used under medical supervision. Patients should be monitored for tolerance and therapeutic response. It is not intended for the immediate relief of acute bronchospasm.
Would you like this description customized for a product catalog, patient leaflet, or online listing?
